The Prostaglandin G/H Synthase 2 pipeline drugs market research report outlays comprehensive information on the Prostaglandin G/H Synthase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Prostaglandin G/H Synthase 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Central Nervous System, Immunology, Musculoskeletal Disorders, and Oncology which include the indications Pain, Post-Operative Pain, Inflammation, Rheumatoid Arthritis, Osteoarthritis, Gouty Arthritis (Gout), Solid Tumor, and Bile Duct Cancer (Cholangiocarcinoma). It also reviews key players involved in Prostaglandin G/H Synthase 2 targeted therapeutics development with respective active and dormant or discontinued products.
The Prostaglandin G/H Synthase 2 pipeline targets constitutes close to 137 molecules. Out of which, approximately 125 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, IND/ CTA Filed, Preclinical, and Discovery stages are 5, 23, 28, 24, 4, 29, and 7 respectively. Similarly, the universities portfolio in Preclinical, and Discovery comprises 5, and 6 molecule.
Prostaglandin G/H Synthase 2 overview
Prostaglandin G/H synthase 2 (PGHS-2) also known as cyclooxygenase-2 (COX-2), is an enzyme that plays a crucial role in the production of prostaglandins, which are hormone-like molecules involved in various physiological processes including inflammation, pain, and fever. PGHS-2 is an inducible enzyme, whose expression is typically induced in response to specific stimuli, such as inflammatory mediators, growth factors, and cellular stress.
For a complete picture of Prostaglandin G/H Synthase 2’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.